BeOne Medicines
Laura Mori is a highly experienced clinical operations professional, currently serving as Clinical Study Senior Manager at BeOne Medicines since April 2025 and at BeiGene since May 2022. With a strong background in clinical operations management, Laura has held key positions at IQVIA, including Senior Clinical Lead and Clinical Operation Quality Specialist, where expertise in project management, quality assurance, and operational excellence were demonstrated. Academic credentials include a PhD in Experimental Pathology and Neuropathology from Università degli Studi di Milano, complemented by a biotechnology degree with honors. Laura's contributions have significantly advanced clinical study leadership and quality management in various therapeutic settings.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.